Cardiac Involvement in Children Affected by COVID-19: Clinical Features and Diagnosis
-
Published:2022-12-30
Issue:1
Volume:13
Page:120
-
ISSN:2075-4418
-
Container-title:Diagnostics
-
language:en
-
Short-container-title:Diagnostics
Author:
Vasichkina ElenaORCID, Alekseeva Daria, Karev Vadim, Podyacheva EkaterinaORCID, Kudryavtsev Igor, Glushkova Anzhela, Starshinova Anastasia Y., Kudlay DmitryORCID, Starshinova Anna
Abstract
COVID-19 (Coronavirus disease 2019) in children is usually mild. However, multiple organ disorders associated with SARS-CoV-2 (severe acute respiratory syndrome-related coronavirus 2) have been detected with poor respiratory symptoms. Cardiac changes are noted in 17% to 75% of cases, which are associated with diagnostic difficulties in high-risk groups for the development of complications that are associated with myocardial damage by the SARS-CoV-2 virus. The objective of this review is to identify the most significant symptoms of cardiac involvement affected by COVID-19, which require in-depth examination. The authors analyzed publications from December 2019 to the October 2022, which were published in accessible local and international databases. According to the analysis data, the main sign of myocardial involvement was increasing as cardiomarkers in the patient’s blood, in particular troponin I or troponin T. Many authors noted that the increased level of CRP (C-reactive protein) and NT-proBNP, which are accompanied by changes in the ECG (electrocardiogram) and EchoCG (echocardiography), as a rule, were nonspecific. However, the identified cardiac functional dysfunctions affected by SARS-CoV-2, required an cardiac MRI. The lack of timely diagnosis of myocardial involvements, especially in children at high risk for the development of complications associated with SARS-CoV-2 myocardial injury, can lead to death. The direct damage of the structural elements of myocardial blood vessels in patients with severe hypoxic changes resulted from respiratory failure caused by SARS-CoV-2 lung damage, with the development of severe acute diffuse alveolar damage and cell-mediated immune response and myocardial involvement affected by SARS-CoV-2 damage. In this article, the authors introduce a clinical case of a child who dead from inflammatory myocardities with COVID-19 in a background of congenital heart disease and T-cell immunodeficiency.
Funder
Ministry of Science and Higher Education of the Russian Federation
Subject
Clinical Biochemistry
Reference69 articles.
1. BNT162b2 Protection against the Omicron Variant in Children and Adolescents;Price;N. Engl. J. Med.,2022 2. Malkova, A.M., Kudlay, D.A., Kudryavtsev, I.V., Starshinova, A.A., Yablonsky, P.K., and Shoenfeld, Y. (2021). Immunogenetic predictors of severe COVID-19. Vaccines, 9. 3. Starshinova, A.A., Malkova, A.M., Zinchenko, Y.U.S., Kudlay, D.A., Glushkova, A.V., Dovgalyk, I., Yablonskiy, P., and Shoenfeld, Y.E. (2021). Efficacy of different types of therapy for COVID-19: A comprehensive review. Life, 11. 4. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province;Liu;Chin. Med. J.,2020 5. Wang, L., Berger, N.A., Kaelber, D.C., Pamela, B., Davis, P.B., Volkow, N.D., and Xu, R. (2022). Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron. medRxiv.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|